Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Cervical Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01581970
What this trial is testing

Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)UnknownNCT05898373
What this trial is testing

Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC

Who this might be right for
Salivary Gland Cancer
Peking Union Medical College 120
Not applicableUnknownNCT04654403
What this trial is testing

Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 337
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)UnknownNCT05310331
What this trial is testing

Donafenib for Recurrent Cervical Cancer

Who this might be right for
Targeted TherapyChemotherapyRecurrent Cervical Carcinoma+4 more
Lei Li 20
Not applicableStudy completedNCT04606940
What this trial is testing

Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)

Who this might be right for
Head and Neck CancerAdvanced CancerMetastatic Cancer+2 more
University Health Network, Toronto 18
Testing effectiveness (Phase 2)Study completedNCT01969578
What this trial is testing

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Who this might be right for
Salivary Gland Cancer
European Organisation for Research and Treatment of Cancer - EORTC 149
Testing effectiveness (Phase 2)WithdrawnNCT04731740
What this trial is testing

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaThyroid Gland Anaplastic Carcinoma by AJCC V8 Stage
Saint Petersburg State University, Russia
Early research (Phase 1)Study completedNCT04477759
What this trial is testing

Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasm
Medical College of Wisconsin 18
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Early research (Phase 1)Study completedNCT04291079
What this trial is testing

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

Who this might be right for
Cancer
Scholar Rock, Inc. 112
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT01613768
What this trial is testing

Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer

Who this might be right for
Recurrent Salivary Gland CancerStage IVA Salivary Gland CancerStage IVB Salivary Gland Cancer+1 more
University of Washington 29
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT06238635
What this trial is testing

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Who this might be right for
Cervical CancerAdvanced Cervical CarcinomaMetastatic Cervical Cancer+2 more
Meghan Shea 66
Early research (Phase 1)Looking for participantsNCT05194982
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Testing effectiveness (Phase 2)Ended earlyNCT00106262
What this trial is testing

Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Who this might be right for
Cervical Cancer
Women and Infants Hospital of Rhode Island 38
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062
What this trial is testing

SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Next Page